1
![Laxai Pharma]()
![Laxai Pharma]()
![Laxai Pharma]()
Laxai Pharma
Leadership team
Mr. J. Ram Ajjarapu (Exec. Chairman)
Ms. Aruna Raj Ajjarapu (Sec.)
Dr. Shailesh Dave Ph.D. (Chief Scientific Officer)
Products/ Services
Pharmaceutical
Number of Employees
0 - 50
Headquarters
Tampa, Florida, United States
Established
2004
Company Registration
SEC CIK number: 0000835688
Revenue
2M - 5M
Traded as
OTC Pink:LAXAF
Overview
Location
Summary
Laxai Pharma, Ltd. offers contract research services in the United States. It provides integrated services across the drug development spectrum. The company focuses its services in the areas of biostatistics, data management (EDC, Hybrid, and Paper), CDISC consulting, medical writing, monitoring, regulatory, drug safety, and related training programs. The company was formerly known as Nexgen Biofuels Ltd. and changed its name to Laxai Pharma, Ltd. in February, 2010. Laxai Pharma, Ltd. is based in Tampa, Florida.
History
Laxai Pharma was founded in 2002, with the vision to be globally recognized pharmaceutical company excel at providing contract development and manufacturing services.
Mission
To provide our customers with the highest quality and differentiated services through innovation, process improvements and robust operations.
Vision
To be a globally recognized pharmaceutical company that provides quality service based on innovation to our customer’s.
Key Team
Mr. Richard A. Field (VP of Sales and Marketing)
Mr. C. Ramachandra Rao (CFO & Director of Laxai Avanti Life Sciences Pvt Ltd)
Recognition and Awards
In 2018, Laxai Pharma was awarded the Best Contract Development and Manufacturing Organization by Frost & Sullivan.
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Leadership team
Mr. J. Ram Ajjarapu (Exec. Chairman)
Ms. Aruna Raj Ajjarapu (Sec.)
Dr. Shailesh Dave Ph.D. (Chief Scientific Officer)
Products/ Services
Pharmaceutical
Number of Employees
0 - 50
Headquarters
Tampa, Florida, United States
Established
2004
Company Registration
SEC CIK number: 0000835688
Revenue
2M - 5M
Traded as
OTC Pink:LAXAF